Can Hydrogen Help Rheumatoid Arthritis? What a Randomized Pilot Trial Found

Most molecular hydrogen research uses drinking water, but this trial tested a different delivery method — hydrogen dissolved directly into saline solution and given intravenously — in a disease driven heavily by inflammation and oxidative stress.

What the research looked at

Published in International Immunopharmacology in 2014, this randomized, double-blind, placebo-controlled pilot study enrolled 24 patients with rheumatoid arthritis. Participants were randomly assigned 1:1 to receive either hydrogen-dissolved saline or plain saline, infused intravenously once daily for five days. Researchers tracked DAS28 (the standard 28-joint disease activity score for RA), along with inflammatory markers TNF-alpha, IL-6, and MMP-3, and a urinary marker of oxidative DNA damage (8-OHdG), over four weeks.

What they found

In the hydrogen group, average DAS28 dropped from 5.18 to 4.02 immediately after the five-day infusion course, and continued down to 3.74 by four weeks — with no significant change in the placebo group over the same period. IL-6 fell by an average of 37% in the hydrogen group, while it rose by 34% in the placebo group. The oxidative stress marker 8-OHdG also decreased significantly in the hydrogen group.

What this means in practice

This is a small pilot study (24 patients) using an intravenous delivery method that isn't how at-home hydrogen water products work — so it's evidence for hydrogen's biological effect on inflammation and oxidative stress in RA, not a direct endorsement of any particular consumer product or delivery route. It's a genuinely encouraging early signal for a difficult, inflammation-driven disease, but it needs a larger trial — and ideally one testing oral hydrogen water specifically — before it says much about what you'd experience drinking hydrogen water at home. Rheumatoid arthritis should always be managed with a rheumatologist's guidance.